a fresh approach to treating C. c. difficile infection FDA-approved.

Published Date: 31 May 2023

The U. S. The Food and Drug Administration (FDA) has approved VOWST, a therapeutic based on the microbiota to stop the recurrence of C. Adults with recurrent Clostridium difficile Infection (CDI) that was treated with antibiotics. The .

Read Full News

Latest News

Can Intraperitoneal Paclitaxel Improve OS in Gastric Cancer?

A phase 3 trial explores whether adding intraperitoneal paclitaxel to intravenous paclitaxel plus S-1 improves overall survival in patients with gastric cancer and peritoneal metastasis.

Pancreatic Cancer Testing Falls Short of Goals

Researchers conducted a cross-sectional electronic survey to see whether respondents were offered and completed germline genetic testing following a pancreatic ductal adenocarcinoma diagnosis.

Pancreatic Cysts: What’s the Actual Cancer Risk?

Pancreatic cysts are common and usually considered low risk — but even those lesions signal a significantly elevated and sustained cancer risk.

UTI Treatment Shift: Is Nitrofurantoin Coming Out on Top?

A large Spanish trial reports higher cure rates with 5-day nitrofurantoin therapy than with fosfomycin or pivmecillinam in women with uncomplicated UTIs.

Takeda Engaged in Antitrust Scheme to Delay Generic Constipation Drug, US Jury Finds

A U.S. jury on Monday found Takeda Pharmaceutical liable for causing about $885 million in damages by delaying a generic version of its constipation drug Amitiza through an...

Blood Proteins Link Poor Sleep to Increased Cancer Risk

Suboptimal sleep health, reflected in low sleep proteomic scores, is consistently associated with an increased risk for cancer, particularly gastrointestinal malignancies.

Todays Updates

Italy's Arbovirus Threat: Is Europe at Greater Risk?

Experts say arboviral outbreaks are becoming a growing public health concern in Europe because of expanding mosquito activity and climate shifts.

Todays Updates

Italy's Arbovirus Threat: Is Europe at Greater Risk?

Experts say arboviral outbreaks are becoming a growing public health concern in Europe because of expanding mosquito activity and climate shifts.

Latest News

A phase 3 trial explores whether adding intraperitoneal paclitaxel to intravenous paclitaxel plus S-1 improves overall survival in patients with gastric cancer and peritoneal metastasis.

Researchers conducted a cross-sectional electronic survey to see whether respondents were offered and completed germline genetic testing following a pancreatic ductal adenocarcinoma diagnosis.

Pancreatic cysts are common and usually considered low risk — but even those lesions signal a significantly elevated and sustained cancer risk.

A large Spanish trial reports higher cure rates with 5-day nitrofurantoin therapy than with fosfomycin or pivmecillinam in women with uncomplicated UTIs.

A U.S. jury on Monday found Takeda Pharmaceutical liable for causing about $885 million in damages by delaying a generic version of its constipation drug Amitiza through an...

Suboptimal sleep health, reflected in low sleep proteomic scores, is consistently associated with an increased risk for cancer, particularly gastrointestinal malignancies.

News All Time

Navigating Personalized Management of Advanced Upper GI Adenocarcinomas

Navigating Personalized Management of Advanced Upper GI Adenocarcinomas

Precision Pathways: Matching Test Results to Therapy in Advanced G/GEJ Adenocarcinoma

Precision Pathways: Matching Test Results to Therapy in Advanced G/GEJ Adenocarcinoma

Clinical Pearls to Advance Multidisciplinary Team-Based Care for Patients With GEP-NETs

Clinical Pearls to Advance Multidisciplinary Team-Based Care for Patients With GEP-NETs

Navigating the Future of Upper GI Cancer Treatment: Mechanisms, Personalization, and Expert Insights

Navigating the Future of Upper GI Cancer Treatment: Mechanisms, Personalization, and Expert Insights

Checkpoint, Claudin, and Beyond: Optimizing Biomarker-Driven Decisions in Advanced/Metastatic G/GEJ Cancer Care

Checkpoint, Claudin, and Beyond: Optimizing Biomarker-Driven Decisions in Advanced/Metastatic G/GEJ Cancer Care

EASL: European Association for the Study of the Liver

ACG: American College of Gastroenterology

AASLD: American Association for the Study of Liver Diseases

AASLD Video Pearls: Video Pearls from the American Association for the Study of Liver Diseases

CCC: Crohn's & Colitis Congress

Dulaglutide or Tirzepatide? Worldwide Biopharma Changes

Also in TTHealthWatch: how treatments for hepatitis C have been used

Raw Dairy Farm Recalls Cheese Products as FDA Investigates E. Coli Outbreak

The company initially refused to recall the products

Multiple Drugs Flagged for Higher C. Diff Risk

Increased risks observed for analgesics and corticosteroids, among others, in Swedish study

Is Surveillance Colonoscopy Needed for Elderly Patients With Adenomas?

Study finds deaths from other causes far surpass colorectal cancer diagnosis, death

Gaslighting in Gastro Care; Antidepressants and IBS Mortality; Diverticulitis Season

News and commentary from the world of gastroenterology and hepatology

Is Kissing for Celiacs Gluten-Free? Study Weighs In

Small trial finds little in the way of gluten transfer when celiac and non-celiac partners kiss

Recommended News For You

Axatilimab Demonstrates Effectiveness in Refractory/Recurrent GVHD.

Geriatric Assessment, QoL Correlate With OS in Older Patients with Pancreatic Cancer

In cases of metastatic or recurrent head and neck cancer, gene-guided immunotherapy falls short.

Exercise could ease symptoms for people with chronic lymphocytic leukemia, support and guidance are lacking: Study

Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.

Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.

Can Prior Authorization Be Better With Artificial Intelligence?

Recommended Articles For You

Oncologic Emergencies: Diagnosis and Treatment 

Introduction To Immune Thrombocytopenic Purpura 

New Research on Craniopharyngioma  

Mastering Surgical Oncology: Education, Certification, Trials, and Therapy Insights 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

An ancient signaling pathway and 20 years of research offer hope for rare cancer

2.

Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus

3.

Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study

4.

I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.

5.

Prostate cancer detection with PET CT and PET MRI is comparable.

1.

Cutting-Edge Cancer Care: The Precision Revolution in Surgical Oncology

2.

Decoding the Padua Score to Prevent Blood Clots in High-Risk Patients

3.

Exploring The Causes and Consequences of Low Transferrin Saturation

4.

Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation

5.

Living with Shwachman-Diamond Syndrome: A Journey of Hope and Strength

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

3.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I

4.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

5.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot